Clinical Trials
3 trialsNCT03517956 2022-07-14
ROCOCO
Bayer
Phase 1 Completed
NCT03788603 2021-03-29
Rogaratinib (BAY1163877) in Chinese Patients
Bayer
Phase 1 Completed
NCT02592785 2018-04-18
Phase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
Bayer
Phase 1 Completed